Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Ltd

₹ 1,724 0.10%
23 May - close price
About

Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Key Points

Hospital Portfolio[1][2]
- India: 19 owned/operated hospitals, 2 heart centers, 18 clinics, and dialysis centers.
- Cayman Islands: 1 hospital.
** - Total:** 40 healthcare facilities with 5,789 operational beds (including Cayman).

  • Market Cap 35,240 Cr.
  • Current Price 1,724
  • High / Low 1,873 / 1,080
  • Stock P/E 81.7
  • Book Value 107
  • Dividend Yield 0.23 %
  • ROCE 19.4 %
  • ROE 21.4 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 43.9% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 19.9%

Cons

  • Stock is trading at 16.1 times its book value
  • The company has delivered a poor sales growth of 9.90% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
620 695 747 738 785 797 852 771 846 872 934 865 919
544 595 621 606 665 659 688 633 690 715 752 708 743
Operating Profit 77 101 125 131 119 138 164 138 156 157 183 157 176
OPM % 12% 14% 17% 18% 15% 17% 19% 18% 18% 18% 20% 18% 19%
83 5 27 9 60 9 14 11 89 14 13 9 107
Interest 10 9 9 12 14 13 13 13 14 20 20 21 26
Depreciation 30 31 31 38 39 38 39 41 44 39 42 43 46
Profit before tax 119 65 112 90 127 96 126 95 187 110 134 101 211
Tax % 35% 35% 35% 35% 28% 18% 13% 17% 15% 22% 21% 22% 24%
78 43 73 58 92 79 109 79 158 86 106 79 160
EPS in Rs 3.80 2.08 3.56 2.86 4.50 3.86 5.33 3.85 7.74 4.23 5.16 3.88 7.83
Raw PDF
Upcoming result date: today

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,076 1,308 1,470 1,646 1,848 2,077 2,239 1,655 2,412 2,965 3,266 3,590
960 1,182 1,295 1,427 1,664 1,881 1,971 1,676 2,146 2,471 2,656 2,919
Operating Profit 115 126 175 219 184 196 268 -21 266 494 609 672
OPM % 11% 10% 12% 13% 10% 9% 12% -1% 11% 17% 19% 19%
25 10 2 14 16 17 19 71 104 95 120 142
Interest 29 38 23 17 26 43 55 48 45 55 65 88
Depreciation 55 64 67 68 78 91 128 123 119 139 161 169
Profit before tax 56 34 86 147 95 79 104 -121 206 395 503 557
Tax % 36% 38% 34% 35% 39% 37% 35% -35% 35% 33% 16% 23%
36 21 57 95 58 50 68 -79 134 266 425 431
EPS in Rs 1,107.25 1.05 2.77 4.65 2.86 2.45 3.31 -3.85 6.54 13.00 20.77 21.10
Dividend Payout % 0% 0% 0% 0% 0% 41% 30% 0% 15% 19% 19% 21%
Compounded Sales Growth
10 Years: 11%
5 Years: 10%
3 Years: 14%
TTM: 10%
Compounded Profit Growth
10 Years: 35%
5 Years: 44%
3 Years: 47%
TTM: 2%
Stock Price CAGR
10 Years: %
5 Years: 45%
3 Years: 41%
1 Year: 37%
Return on Equity
10 Years: 12%
5 Years: 16%
3 Years: 22%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.33 200 204 204 204 204 204 204 204 204 204 204
Reserves 569 595 753 854 916 963 962 885 1,021 1,264 1,636 1,981
321 289 152 120 491 499 607 551 533 644 1,011 1,595
237 216 274 309 383 410 449 462 528 664 645 718
Total Liabilities 1,128 1,300 1,383 1,487 1,995 2,077 2,222 2,103 2,285 2,777 3,496 4,499
626 651 650 682 973 949 1,159 1,070 1,094 1,358 1,480 2,341
CWIP 12 9 13 52 30 56 3 5 23 32 34 27
Investments 51 241 334 354 561 597 619 645 661 678 1,021 1,166
438 399 386 399 431 475 441 382 507 709 962 964
Total Assets 1,128 1,300 1,383 1,487 1,995 2,077 2,222 2,103 2,285 2,777 3,496 4,499

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
164 61 177 218 196 208 286 123 246 516 542
-172 -192 -130 -162 -446 -137 -129 -12 -117 -621 -761
5 127 -2 -32 226 -11 -170 -114 -57 65 237
Net Cash Flow -3 -4 46 25 -24 61 -12 -3 72 -40 19

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 45 40 34 31 37 28 24 34 26 22 21 25
Inventory Days 63 55 46 42 41 36 24 19 18 17 28 19
Days Payable 206 136 142 161 179 165 171 237 177 211 192 168
Cash Conversion Cycle -98 -41 -62 -88 -102 -101 -124 -184 -133 -172 -143 -124
Working Capital Days -12 6 3 -1 -5 -15 -23 -34 -23 -27 -23 12
ROCE % 9% 7% 11% 15% 9% 8% 9% -4% 15% 23% 23% 19%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85%
10.03% 9.55% 10.24% 10.36% 11.10% 11.59% 11.51% 10.91% 10.01% 9.69% 9.45% 9.66%
17.85% 16.62% 14.58% 14.14% 11.95% 10.89% 10.23% 9.51% 8.22% 7.90% 8.68% 8.52%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.00% 0.00% 0.00%
7.59% 9.28% 10.70% 11.01% 12.45% 13.05% 13.78% 15.12% 17.29% 17.94% 17.39% 17.34%
0.69% 0.69% 0.63% 0.63% 0.63% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62%
No. of Shareholders 65,17368,13073,15775,37086,6311,02,9941,20,5061,38,0521,60,6861,78,3561,77,7921,85,787

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls